Status:
COMPLETED
Effects of Microcirculation-assisted Adjustment of Blood Flow of VA-ECMO on Prognosis
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Microcirculation
Extracorporeal Membrane Oxygenation
Eligibility:
All Genders
20-89 years
Phase:
NA
Brief Summary
One of the key factors of survival of patients with extra-corporeal membrane oxygenation (ECMO) life support system is whether the blood flow supplied by ECMO can meet the need of perfusion of each or...
Detailed Description
For severe cardiac and respiratory failure patients, extra-corporeal membrane oxygenation (ECMO) life support system can help them to have time to wait for the recovery of cardiac and respiratory func...
Eligibility Criteria
Inclusion
- patients with venoarterial extra-corporeal membrane oxygenation
Exclusion
- unable to receive microcirculation within 18 hours after placement of venoarterial extra-corporeal membrane oxygenation
- non-native speakers and family
Key Trial Info
Start Date :
December 19 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 2 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03470792
Start Date
December 19 2018
End Date
February 2 2021
Last Update
March 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100